Squarepoint’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Sell
10,900
-7,000
-39% -$2.21M ﹤0.01% 1902
2026
Q1
$5.88M Buy
17,900
+14,900
+497% +$5.35M 0.01% 1381
2025
Q4
$1.05M Sell
3,000
-300
-9% -$109K ﹤0.01% 2557
2025
Q3
$1.22M Sell
3,300
-7,100
-68% -$2.74M ﹤0.01% 2513
2025
Q2
$4.11M Buy
10,400
+4,800
+86% +$1.8M ﹤0.01% 1591
2025
Q1
$2.08M Sell
5,600
-14,800
-73% -$5.63M ﹤0.01% 2058
2024
Q4
$7.35M Buy
20,400
+12,100
+146% +$4.48M 0.01% 1348
2024
Q3
$3M Buy
8,300
+4,300
+108% +$1.48M ﹤0.01% 1777
2024
Q2
$1.36M Sell
4,000
-11,200
-74% -$3.79M ﹤0.01% 2338
2024
Q1
$5.44M Buy
+15,200
New +$5.11M 0.01% 1378
2023
Q4
Sell
-8,400
Closed -$2.3M 4493
2023
Q3
$2.3M Sell
8,400
-12,700
-60% -$3.64M 0.01% 1711
2023
Q2
$6.44M Buy
21,100
+18,500
+712% +$5.34M 0.02% 934
2023
Q1
$742K Buy
2,600
+300
+13% +$79.6K ﹤0.01% 2083
2022
Q4
$562K Sell
2,300
-4,000
-63% -$908K ﹤0.01% 2209
2022
Q3
$1.28M Hold
6,300
0.01% 1595
2022
Q2
$1.25M Buy
+6,300
New +$1.48M 0.01% 1468

Other funds holding SYK

Squarepoint's SYK Position: Q2 2026 in Review

Squarepoint reduced its Stryker (SYK) stake by 85% in Q2 2026, selling an estimated $29.3M and leaving 17,021 shares worth $5.36M. The position accounts for 0.01% of the portfolio, ranked #1553.

Squarepoint first reported a position in SYK in Q1 2015 and has held it in 29 quarters since. The position peaked at $287M in Q3 2025. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Squarepoint held 17,021 shares of Stryker worth $5.36M as of Q2 2026.
  • Squarepoint sold 92,943 Stryker shares in Q2 2026, an estimated $29.3M.
  • Stryker made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1553 holding.
  • Squarepoint first reported a position in Stryker in Q1 2015 and has held it in 29 quarters since.
  • Squarepoint's Stryker position peaked at $287M in Q3 2025.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.